Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity
Background: Renal cell carcinoma (RCC) is frequently associated with paraneoplastic inflammatory syndrome (PIS). This study aimed at exploring the connections between the survival rate and specific gene alterations and the potential mechanism. Methods: We retrospectively studied 69 surgical RCC case...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2176;epage=2182;aulast=Wang |
_version_ | 1828393271993303040 |
---|---|
author | Gang Wang Da-Ming Zhang Hai-Ying Zhuang Chao Yin Jing Liu Zi-Chun Wang Li-Cheng Cai Ming-Hua Ren Wan-Hai Xu Cheng Zhang |
author_facet | Gang Wang Da-Ming Zhang Hai-Ying Zhuang Chao Yin Jing Liu Zi-Chun Wang Li-Cheng Cai Ming-Hua Ren Wan-Hai Xu Cheng Zhang |
author_sort | Gang Wang |
collection | DOAJ |
description | Background: Renal cell carcinoma (RCC) is frequently associated with paraneoplastic inflammatory syndrome (PIS). This study aimed at exploring the connections between the survival rate and specific gene alterations and the potential mechanism.
Methods: We retrospectively studied 69 surgical RCC cases from August 2014 to February 2016, including 18 cases of clear cell RCC (ccRCC) demonstrating elevated pretreatment serum C-reactive protein (CRP, Group A). Twelve of the 18 cases were symptomized with febrile episode. We also selected 49 cases of ccRCC with normal pretreatment CRP (Group B). Using 22 microsatellite markers, we compared the incidence of loss of heterozygosity (LOH) between Group A and Group B. All statistical tests are two-sided.
Results: The 3p LOH was common in both Group A (89%) and Group B (92%). The frequency of 14q LOH in Group A (16 of 18) was higher than Group B (4 of 49, χ2 = 40.97 P < 0.0001). The 3p and 14q LOH were the characteristics of ccRCC with elevated acute phase reactants, including PIS, regardless of the presence of metastasis. On the contrary, 14q LOH was a rare genomic alternation in advanced-staged ccRCC without PIS. The overall survival of patients with elevated CRP (33.3%) was lower than its counterparts (6.1%, hazard ratio=1.852, P < 0.0001) in Kaplan-Meier curve.
Conclusions: The results imply that the disruption of a 14q gene(s) might result in not only the inflammatory manifestations in the tumor host but also the poor survival rate as well. The isolation of the gene(s) on 14q might be a vital goal in the treatment of PIS-associated RCC. |
first_indexed | 2024-12-10T07:36:09Z |
format | Article |
id | doaj.art-3e315a2a6a054f24a8ae5f104be84f25 |
institution | Directory Open Access Journal |
issn | 0366-6999 |
language | English |
last_indexed | 2024-12-10T07:36:09Z |
publishDate | 2017-01-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Chinese Medical Journal |
spelling | doaj.art-3e315a2a6a054f24a8ae5f104be84f252022-12-22T01:57:25ZengWolters KluwerChinese Medical Journal0366-69992017-01-01130182176218210.4103/0366-6999.213962Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein AbnormityGang WangDa-Ming ZhangHai-Ying ZhuangChao YinJing LiuZi-Chun WangLi-Cheng CaiMing-Hua RenWan-Hai XuCheng ZhangBackground: Renal cell carcinoma (RCC) is frequently associated with paraneoplastic inflammatory syndrome (PIS). This study aimed at exploring the connections between the survival rate and specific gene alterations and the potential mechanism. Methods: We retrospectively studied 69 surgical RCC cases from August 2014 to February 2016, including 18 cases of clear cell RCC (ccRCC) demonstrating elevated pretreatment serum C-reactive protein (CRP, Group A). Twelve of the 18 cases were symptomized with febrile episode. We also selected 49 cases of ccRCC with normal pretreatment CRP (Group B). Using 22 microsatellite markers, we compared the incidence of loss of heterozygosity (LOH) between Group A and Group B. All statistical tests are two-sided. Results: The 3p LOH was common in both Group A (89%) and Group B (92%). The frequency of 14q LOH in Group A (16 of 18) was higher than Group B (4 of 49, χ2 = 40.97 P < 0.0001). The 3p and 14q LOH were the characteristics of ccRCC with elevated acute phase reactants, including PIS, regardless of the presence of metastasis. On the contrary, 14q LOH was a rare genomic alternation in advanced-staged ccRCC without PIS. The overall survival of patients with elevated CRP (33.3%) was lower than its counterparts (6.1%, hazard ratio=1.852, P < 0.0001) in Kaplan-Meier curve. Conclusions: The results imply that the disruption of a 14q gene(s) might result in not only the inflammatory manifestations in the tumor host but also the poor survival rate as well. The isolation of the gene(s) on 14q might be a vital goal in the treatment of PIS-associated RCC.http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2176;epage=2182;aulast=WangC-reactive Protein; Gene Alterations; Loss of Chromosome; Paraneoplastic Inflammatory Syndrome; Renal Cell Carcinoma |
spellingShingle | Gang Wang Da-Ming Zhang Hai-Ying Zhuang Chao Yin Jing Liu Zi-Chun Wang Li-Cheng Cai Ming-Hua Ren Wan-Hai Xu Cheng Zhang Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity Chinese Medical Journal C-reactive Protein; Gene Alterations; Loss of Chromosome; Paraneoplastic Inflammatory Syndrome; Renal Cell Carcinoma |
title | Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity |
title_full | Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity |
title_fullStr | Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity |
title_full_unstemmed | Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity |
title_short | Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity |
title_sort | roles of loss of chromosome 14q allele in the prognosis of renal cell carcinoma with c reactive protein abnormity |
topic | C-reactive Protein; Gene Alterations; Loss of Chromosome; Paraneoplastic Inflammatory Syndrome; Renal Cell Carcinoma |
url | http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=18;spage=2176;epage=2182;aulast=Wang |
work_keys_str_mv | AT gangwang rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT damingzhang rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT haiyingzhuang rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT chaoyin rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT jingliu rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT zichunwang rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT lichengcai rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT minghuaren rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT wanhaixu rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity AT chengzhang rolesoflossofchromosome14qalleleintheprognosisofrenalcellcarcinomawithcreactiveproteinabnormity |